HomeOpen Access NewsHealthcare Innovation

Healthcare Innovation

Whitepaper: Emerging tech and scalable EPR: Driving NHS digital transformation in 2025

In 2025 the NHS faces a pivotal year in its digital transformation journey, guided by ambitious national policies and propelled by new technologies.

Research finds serotonin increase after three month depression treatment

A team at the Karolinska Institutet found that some patients who recovered by accessing depression treatment showed an increase in their average level of serotonin transporter.

What happens now that the US supports the TRIPS waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.

CureVac mRNA vaccine can be stored at normal fridge temperature

The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.

Scientists find that tear gas exposure harms menstrual cycle

In this study, nearly 900 people described an abnormal menstrual cycle after exposure to tear gas - which is legally considered to be "safe" as a crowd control measure.

Doctors stop vaccine-blood clot with heparin alternative

A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.

Pfizer applies for COVID vaccine to be given to 12-year-olds

Pfizer could make their COVID vaccine available to 12-year-olds in Europe from June, after clinical trials in March showed 100% efficiency for those aged 12 to 15.

Turning the national illness service into the national health service

Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.

Brazilian COVID mutation more likely to evade immunity

The city of Manaus was hit so overwhelmingly by the Brazilian COVID mutation, it was believed that 75% of the population had COVID - what new truths are scientists learning about this powerful variant? 

One in four people get Pfizer and AstraZeneca vaccine side effects

New data from the UK's vaccination programme suggests that one in four people get Pfizer and AstraZeneca vaccine side effects - with most peaking in the first 24 hours, then gone in two days.

How is COVID impacting racial minorities with opioid use disorder?

Researchers worked with racial minorities with opioid use disorder to document how this doubly-vulnerable group were impacted by COVID.

Scientists work on blood test to diagnose heart attacks

Scientists are creating a blood test that can quickly diagnose heart attacks - by looking for the "unique fingerprint" of a heart attack.

Is the Indian ‘double mutation’ as dangerous as the UK mutation?

India broke records on Thursday (23 April) as more than 310,000 new COVID cases were documented in one day - is the Indian 'double mutation', B1617, as infectious as the UK mutation? 

Scientists find link between emotional regulation and PTSD

Researchers believe that they have found a PTSD marker in the brain region associated with emotional regulation - with the marker being strongest in people with "impaired executive dysfunction".

Scientists find Black women four times likelier to die of COVID

Researchers at Harvard University found that Black women are four times more likely to die of COVID than white men - the data also revealed that Black women are three times more likely to die of the virus than Asian men.

New study will investigate long-term effects of COVID-19 lung damage

A new national study, funded by UK Research and Innovation (UKRI), will investigate the long-term effects of COVID-19 lung damage.

Pfizer says people will need third vaccine dose after 12 months

Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders